multi-array ® assay system (Meso Scale Diagnostics LLC)
Structured Review
Multi Array ® Assay System, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multi-array+system/multi+array+assay+system/pmc07824960-122-9-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
Electrochemiluminescence:Article Title: A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults Article Snippet: Leptin and GLP-1 were measured by electro-chemiluminescence using the Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Article Snippet: 330 331 Bridging electrochemiluminescence assay for TAb 332 AAV5 TAb was assayed in human plasma using a validated semi-quantitative bridging 333 chemiluminescence assay with the Article Title: Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session Article Snippet: Leptin and GLP-1 were measured by electrochemiluminescence using the Article Title: Correlations between personality traits, personality disorders, and immunometabolic markers Article Snippet: Immunometabolic markers were measured using a commercially available assay, in accordance with the manufacturer’s protocol (MULTI-ARRAY Assay Article Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK Article Snippet: In some embodiments, an electrochemiluminescence detection assay or an assay relying on a combination of electrochemiluminescence and patterned array technology is used (e.g., an ECL or MULTI-ARRAY technology assay from Detection Assay:Article Title: A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults Article Snippet: Leptin and GLP-1 were measured by electro-chemiluminescence using the Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Article Snippet: 330 331 Bridging electrochemiluminescence assay for TAb 332 AAV5 TAb was assayed in human plasma using a validated semi-quantitative bridging 333 chemiluminescence assay with the Article Title: Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session Article Snippet: Leptin and GLP-1 were measured by electrochemiluminescence using the Article Title: Correlations between personality traits, personality disorders, and immunometabolic markers Article Snippet: Immunometabolic markers were measured using a commercially available assay, in accordance with the manufacturer’s protocol (MULTI-ARRAY Assay Article Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK Article Snippet: In some embodiments, an electrochemiluminescence detection assay or an assay relying on a combination of electrochemiluminescence and patterned array technology is used (e.g., an ECL or MULTI-ARRAY technology assay from Clinical Proteomics:Article Title: A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults Article Snippet: Leptin and GLP-1 were measured by electro-chemiluminescence using the Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Article Snippet: 330 331 Bridging electrochemiluminescence assay for TAb 332 AAV5 TAb was assayed in human plasma using a validated semi-quantitative bridging 333 chemiluminescence assay with the Article Title: Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session Article Snippet: Leptin and GLP-1 were measured by electrochemiluminescence using the Article Title: Correlations between personality traits, personality disorders, and immunometabolic markers Article Snippet: Immunometabolic markers were measured using a commercially available assay, in accordance with the manufacturer’s protocol (MULTI-ARRAY Assay Article Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK Article Snippet: In some embodiments, an electrochemiluminescence detection assay or an assay relying on a combination of electrochemiluminescence and patterned array technology is used (e.g., an ECL or MULTI-ARRAY technology assay from Chemiluminescence Immunoassay:Article Title: A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults Article Snippet: Leptin and GLP-1 were measured by electro-chemiluminescence using the Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Article Snippet: 330 331 Bridging electrochemiluminescence assay for TAb 332 AAV5 TAb was assayed in human plasma using a validated semi-quantitative bridging 333 chemiluminescence assay with the Article Title: Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session Article Snippet: Leptin and GLP-1 were measured by electrochemiluminescence using the Article Title: Correlations between personality traits, personality disorders, and immunometabolic markers Article Snippet: Immunometabolic markers were measured using a commercially available assay, in accordance with the manufacturer’s protocol (MULTI-ARRAY Assay Article Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK Article Snippet: In some embodiments, an electrochemiluminescence detection assay or an assay relying on a combination of electrochemiluminescence and patterned array technology is used (e.g., an ECL or MULTI-ARRAY technology assay from Incubation:Article Title: A high-protein total diet replacement alters the regulation of food intake and energy homeostasis in healthy, normal-weight adults Article Snippet: Leptin and GLP-1 were measured by electro-chemiluminescence using the Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology. Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology Article Snippet: The overall decrease in plaque load was accompanied by increased soluble and insoluble Aβ40 and Aβ42 in the cortex and hippocampus via Article Title: Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A. Article Snippet: 330 331 Bridging electrochemiluminescence assay for TAb 332 AAV5 TAb was assayed in human plasma using a validated semi-quantitative bridging 333 chemiluminescence assay with the Article Title: Consumption of a High-Protein Meal Replacement Leads to Higher Fat Oxidation, Suppression of Hunger, and Improved Metabolic Profile After an Exercise Session Article Snippet: Leptin and GLP-1 were measured by electrochemiluminescence using the Article Title: Correlations between personality traits, personality disorders, and immunometabolic markers Article Snippet: Immunometabolic markers were measured using a commercially available assay, in accordance with the manufacturer’s protocol (MULTI-ARRAY Assay Article Title: Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK Article Snippet: In some embodiments, an electrochemiluminescence detection assay or an assay relying on a combination of electrochemiluminescence and patterned array technology is used (e.g., an ECL or MULTI-ARRAY technology assay from |
